Video from RSNA 2017: New MagnetVision app helps assess MRI energy fields
CHICAGO - When it comes to MRI safety, wouldn't it be great if you knew exactly...Read more on AuntMinnie.comRelated Reading: Video from RSNA 2017: New program promotes quality in radiology Video from RSNA 2017: Is the future of radiology augmented? Video from RSNA 2017: Perception Lab turns radiologists into research subjects Video from RSNA 2017: Gadolinium retention debate takes center stage Video from RSNA 2017: Cinematic rendering -- Just pretty pictures or paradigm shift? Comments: 12/1/2017 11:55:03 AMekanal A 4 minute "video trailer" of this new MagnetVision app can be found at: https://www.nwforums.com/Kanal%20MagnetVision.mp4
Authors: PMID: 30433921 [PubMed - in process]
PMID: 30433920 [PubMed - in process]
Pediatric Anesthesia Informed Consent: "That's the Signpost Up Ahead - Your Next Stop, The Twilight Zone!" Anesth Analg. 2018 Dec;127(6):1289-1291 Authors: Lauro HV PMID: 30433919 [PubMed - in process]
PMID: 30433918 [PubMed - in process]
PMID: 30433917 [PubMed - in process]
PMID: 30433916 [PubMed - in process]
PMID: 30433915 [PubMed - in process]
PMID: 30433914 [PubMed - in process]
Publication date: Available online 16 November 2018Source: Seminars in Cancer BiologyAuthor(s): Besa Xhabija, Benjamin L. KidderAbstractEpigenetic regulation of chromatin plays a critical role in controlling stem cell function and tumorigenesis. The histone lysine demethylase, KDM5B, which catalyzes the demethylation of histone 3 lysine 4 (H3K4), is important for embryonic stem (ES) cell differentiation, and is a critical regulator of the H3K4-methylome during early mouse embryonic pre-implantation stage development. KDM5B is also overexpressed, amplified, or mutated in many cancer types. In cancer cells, KDM5B regulates e...
Publication date: Available online 16 November 2018Source: Cancer GeneticsAuthor(s): Jennelle C. Hodge, David Bosler, Lauren Rubinstein, Navid Sadri, Shashirekha ShettyAbstractThe inv(3)(q21q26.2) altering a single chromosome 3 homolog is an established myeloid malignancy-associated entity. Comparatively, double inv(3) cases involving both homologs are exceedingly rare with 13 reports across AML, CML and MDS. This scarcity was confirmed by finding only 2 new cases out of 34,898 bone marrows collected during a 55 year period at a large medical center (0.0005%). The double inv(3) was detected by karyotype and confirmed by FI...
More News: Radiology